News & Insights

Get the latest news and updates

News | September 9, 2025

Telacebec, a Potent Agent in the Fight against Tuberculosis

Telacebec is a new first-in-class antituberculosis drug that targets mycobacterial energy production. Preliminary results of a phase 2A proof of concept study showed bactericidal activity with an increase in...

Read more about Telacebec, a Potent Agent in the Fight against Tuberculosis

FILTER BY

News | September 9, 2025

Telacebec, a Potent Agent in the Fight against Tuberculosis

Read more about Telacebec, a Potent Agent in the Fight against Tuberculosis

News | September 3, 2025

Quantification of bactericidal activity using the PATHFAST TB LAM Ag assay during the first 14 days of pulmonary tuberculosis treatment

Read more about Quantification of bactericidal activity using the PATHFAST TB LAM Ag assay during the first 14 days of pulmonary tuberculosis treatment

New Oncology Clinical Trials Unit at Tygerberg Hospital
News | April 22, 2025

TASK and Stellenbosch University Open New Oncology Clinical Trials Unit at Tygerberg Hospital, Bringing Hope to Cancer Patients

Read more about TASK and Stellenbosch University Open New Oncology Clinical Trials Unit at Tygerberg Hospital, Bringing Hope to Cancer Patients

bEto-TB
News | December 12, 2024

bEto-TB

Read more about bEto-TB

Oncology clinical trial
Clinical Trials | November 28, 2024

FHI Clinical & TASK unite to deliver comprehensive oncology trial solution

Read more about FHI Clinical & TASK unite to deliver comprehensive oncology trial solution

UMC Utrecht and TASK collaboration agreement
News | November 5, 2024

The Netherlands and South-Africa take hands in UMC Utrecht and TASK collaboration agreement

Read more about The Netherlands and South-Africa take hands in UMC Utrecht and TASK collaboration agreement

TASK and Parexel join forces to accelerate global vaccine research
News | October 24, 2024

TASK and Parexel join forces to accelerate global vaccine research

Read more about TASK and Parexel join forces to accelerate global vaccine research

TASK Leads International Collaboration Towards Phage Therapy for Tuberculosis
News | October 22, 2024

TASK Leads International Collaboration in Groundbreaking Phages4TB Project Working Towards Phage Therapy for Tuberculosis

Read more about TASK Leads International Collaboration in Groundbreaking Phages4TB Project Working Towards Phage Therapy for Tuberculosis

TB study investigates crushed tablets for TB prevention article cover
BSL-3 Laboratory | October 12, 2023

Groundbreaking TB Study investigates Crushed Tablets for TB Prevention

Read more about Groundbreaking TB Study investigates Crushed Tablets for TB Prevention

Load more

Don't hesitate to get in touch with us if you have any questions or concerns.

Learn more

© 2025 Task. All Rights Reserved.

Privacy Policy | Communication Policy

© 2025 TASK - Applied Science. All Rights Reserved.

Privacy Policy

Communication Policy

South Africa

Smith Street, Glenlily,
Cape Town, 7500

Get directions →

Phone:
+27 (0)21 100 3606

Email:
info@taskclinical.com

The Netherlands

Room Str 1.239A,
Stratenum 1st floor,
UMC Utrecht

Get directions →

Phone:
+31 (0)88 75 56997

Email:
info@taskclinical.com

© 2025 TASK - Applied Science. All Rights Reserved.

Privacy Policy

Communication Policy

The Netherlands

Room Str 1.239A,
Stratenum 1st floor,
UMC Utrecht

Get directions →

Phone:
+31 (0)88 75 56997

Email:
info@taskclinical.com